Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
Morgan SA, Hassan-Smith ZK, Doig CL, Sherlock M, Stewart PM, Lavery GG.
J Endocrinol. 2016 Jun;229(3):277-86. Epub 2016 Apr 5.
doi: https://10.1530/JOE-16-0011.
Advances in treatment of glucocorticoid-induced osteoporosis.
Hsu E, Nanes M.
Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):411-417
doi: https://doi.org/10.1097/MED.0000000000000368
Osteogenesis imperfecta: diagnosis and treatment.
Palomo T, Vilaça T, Lazaretti-Castro M.
Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):381-388
DOI:https://doi.org/10.1097/MED.0000000000000367
The 2017 Bethesda System for Reporting Thyroid Cytopathology.
Cibas ES, Ali SZ.
Thyroid. 2017 Nov;27(11):1341-1346.
doi: http://dx.doi.org/10.1089/thy.2017.0500
PMID: 29091573
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH5 et al.
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903.
doi: http://dx.doi.org/10.1210/jc.2017-01658
Comentarios recientes